Coronary Heart Disease Phospholipase a 2 Enzymes, High-dose Atorvastatin, and Prediction of Ischemic Events after Acute Coronary Syndromes for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (miracl) Trial Investigators Clinical Perspective on P 766 Laboratory and Oxidative Bi